Dr Refai Showkathali

Give Feedback
Dr Refai Showkathali

MBBS, MRCP(UK), FRCP(Lon),CCT in Cardio(UK), FACC(USA), Fellowship in TAVI (Lon),FESC(Eur)

Interventional Cardiologist

Apollo Hospitals Greams Road Chennai
  • 16 Years of experience
  • English,Hindi,Tamil,Malayalam
  • 12 Recommendations
  •  MON-SAT | 09:00 AM-01:45 PM, 01:45 PM-05:00 PM

Awards and Achievements

  • Winner of the academic research poster award- East of England- 2011
  • Runner-up in research proposal of the year award- east of England- 2012
  • Examiner for the MRCP PACES exam by Royal college of Physicians,London
  • Professor Apollo hospitals Educational and Research Foundation
  • One-year fellowship in Transcatheter Aortic Valve Implantation (TAVI) in prestigious King’s College Hospital, London
  • Full accreditation in echocardiography from British society of echocardiography (2008-2013)
  • Trained in world class tertiary cardiac centres in London
  • More than 50 peer reviewed publications in renowned international journals (most of which or first or lead author)- selected few are listed  below.
  • Reviewer of manuscripts for various international cardiology journals for publication.
  • Regulalrly presents papers in various cardiology conferences in North America, UK, Europe and Asia.
  • He was awarded the Fellowship of American College of Cardiology (FACC) and Fellowship of European Society of Cardiology (FESC) recently for his academic achievements.
  • He also has been conferred with the prestigious Fellowship of Royal College of Physicians, London (FRCP, Lon). 
  • He undertook a Fellowship in structural heart disease intervention such as Transcatheter Aortic Valve implantation (TAVI), Balloon aortic valvuloplasty (BAV), PFO and ASD Closure at King’s College Hospital, London. King’s is one of the highest volume TAVI centre in UK performing around 100 TAVIs per annum since Aug 2007.
  • He also performs other invasive procedures like Permanent pacemaker and AICD (Defibrillator) implantation, implantable loop recorder, intra-aortic balloon pump (IABP) insertion, right and left heart catheterisation, Right ventricular (RV) biopsy and transoesophageal echocardiography (TEE). He had full Echo accreditation from British Society of Echocardiography from 2008- 2013.

Research and Publications

RESEARCH:

  • Acute Haemodynamic changes after balloon aortic valvuloplasty (BAV) and transcatheter aortic valve implantation (TAVI). (King’s College Hospital, London
  • Observational study aimed to define the immediate haemodynamic changes after BAV and TAVI and to identify the mechanism of observed LV impairment
  • Co-investigator in the following TAVI related studies: (King’s College Hospital Sapien-3 (Edwards) Valve PORTICO valve JENNA valve
  • Risk scoring model for heart failure (Pilot study): (The Essex CTC)
  • Small pilot study of 150 patients to try and develop a model for risk scoring to predict mortality and re-admission within 30 days of index admission in patients with heart failure.

PUBLICATIONS :

  • The use of Embolic deflector device in TAVI. Refai Showkathali, R Dworakowski, J Byrne, P MacCarthy, London. IHJ Case reports 2016 Valve in Valve implanatation to prevent prosthetic valve migration in TAVI. R Showkathali, R Dworakowski, P MacCarthy, IHJ 2015
  • Incidental findings during TAVI work-up: More than just an inconvenience. - Original article Refai Showkathali, Arup Sen, Rafal Dwarakowski, Beth Brickham, Olaf Wendler, Philip MacCarthy. King’s College Hospital, London.Eurointervention 2014 Jun 28. pii: 20130626-03. doi: 10.4244/EIJY14M06
  • Should primary percutaneous coronary intervention be the routine reperfusion strategy in octogenarians presenting with ST elevation myocardial infarction? Refai Showkathali, Edney Boston-Griffiths, Michael Parker, John R Davies, Gerald J Clesham, Jeremy W Sayer, Paul A Kelly, Rajesh K Aggarwal. The Essex CTC, UK J Cardiovasc Med. 2014; 15(1):53-9
  • Comparison of Bivalirudin with Heparin versus Abciximab with Heparin for primary percutaneous coronary intervention in "real-world" practice. Refai Showkathali, John R Davies, Michael Parker, Wasing Taggu, Kare H Tang, Gerald J Clesham, Reto A Gamma, Jeremy W Sayer, Rajesh K Aggarwal, Paul A Kelly. Cardiovasc Revasc Med. 2013 14(5):289-93
  • The advantages of a consultant led primary percutaneous coronary intervention service on patient outcome.Refai Showkathali, John R Davies, Jeremy W Sayer, Paul A Kelly, Rajesh K Aggarwal, Gerald J Clesham. The Essex Cardiothoracic centre, UK QJM. 2013 Jun 29. 
  • Radio frequency ablation of arrhythmias guided by non-fluoroscopic catheter location: A prospective randomized trial. Mark J Earley, Refai Showkathali, Maysaa Alzetani, Peter M Kistler, Dhiraj Gupta, Dominic J Abram, Julie A Horrocks, Stuart Harris, Simon C Sporton, Richard J Schilling. Eur. Heart J. 2006 May; 27:1223 – 1229
  • Right atrial flutter isthmus ablation is feasible and results in acute clinical improvement in patients with persistent atrial flutter and severe pulmonary arterial hypertension Refai Showkathali, Muzahir H. Tayebjee, Julia Grapsa, Maysaa Alzetani, Petros Nihoyannopoulos, Luke S Howard, David C Lefroy, J Simon R Gibbs. Hammersmith Hospital Int J Cardiol. 2011; 149(2):279-80
  • Multi-disciplinary clinic: Next step in “Heart team” approach for TAVI.
  • Refai Showkathali, Raj Chelliah, Beth Brickham, Rafal Dworakowski, Emma Alcock, Ranjit Deshpande, Olaf Wendler, Philip MacCarthy, Jonathan Byrne.
  • Should primary percutaneous coronary intervention be the routine reperfusion strategy in octogenarians presenting with ST elevation myocardial infarction?
  • Refai Showkathali, Edney Boston-Griffiths, Michael Parker, John R Davies, Gerald J Clesham, Jeremy W Sayer, Paul A Kelly, Rajesh K Aggarwal. The Essex CTC, UK
  • J Cardiovasc Med. 2014; 15(1):53-9
  • Typical Takotsubo Cardiomyopathy in ST elevation myocardial infarction patients admitted for primary percutaneous coronary intervention.- Original article
  • Refai Showkathali, Hetalkumar Patel, Anil Ramoutar, Alamgir M Kabir, Jeremy W Sayer, Gerald J Clesham, Rajesh K Aggarwal, Paul A Kelly.
  • Eur J Intern Med. 2013 Oct 3. doi:pii: S0953-6205(13)00942-4. 10.1016/j.ejim.2013.09.004
  • Comparison of Bivalirudin with Heparin versus Abciximab with Heparin for primary percutaneous coronary intervention in "real-world" practice.
  • Refai Showkathali, John R Davies, Michael Parker, Wasing Taggu, Kare H Tang, Gerald J Clesham, Reto A Gamma, Jeremy W Sayer, Rajesh K Aggarwal, Paul A Kelly.
  • Cardiovasc Revasc Med. 2013 14(5):289-93
  • Current case mix and results of catheter ablation of regular supraventricular tachycardia: are we giving unrealistic expectation to patients?
  • Refai Showkathali, Mark J Earley, Maysaa Alzetani, Stuart Harris, Dhiraj Gupta, Peter Kistler, Simon Sporton, Anthony W Nathan, Richard J Schilling.
  • Europace. November 2007; 9(11): 1064 – 1068
  • Radio frequency ablation of arrhythmias guided by non-fluoroscopic catheter location: A prospective randomized trial.
  • Mark J Earley, Refai Showkathali, Maysaa Alzetani, Peter M Kistler, Dhiraj Gupta, Dominic J Abram, Julie A Horrocks, Stuart Harris, Simon C Sporton, Richard J Schilling.Eur. Heart J. 2006 May; 27:1223 – 1229
  • Takotsubo Cardiomyopathy: a short review.Shahbaz Roshanzamir, Refai Showkathali.Curr Cardiol Rev. 2013;9 (3): 191-6
  • Rosuvastatin calcium in acute coronary syndromes.Rajesh Aggarwal, Refai Showkathali.Expert Opin Pharmacother. 2013 Jun;14(9):1215-27
  • Antiplatelet and Antithrombin Strategies in Acute Coronary Syndrome: State-Of-The-Art Review.Refai Showkathali, Arun Natarajan.Curr Cardiol Rev. 2012;8: 239-49
  • Echocardiography and the critically ill patient.Refai Showkathali, Derek Hausenloy. Hammersmith Hospital, London Current Anaes and Critical Care 2006- Volume 17, Issues 3-4: 237-244
  • He regularly presents research papers in International Cardiology conferences in UK, Europe and USA. He has published extensively in the field of cardiology with more than 50 peer reviewed publications in renowned International Journals, most of which are first or lead author. He also regularly review manuscripts for various cardiology and general medical journals from UK, Europe and USA (Heart, Open Heart, Eurointervention, Indian Heart journal, “Current cardiology review” etc within the last one year)

Qualification

MBBS, MRCP(UK), FRCP(Lon),CCT in Cardio(UK), FACC(USA), Fellowship in TAVI (Lon),FESC(Eur)

Work Experience

  • Currently Working as Senior Consultant Interventional Cardiology at Apollo Hospitals Greams road Chennai 
  • SEPT 2013 - JUNE 2014: Interventional Cardiologist The Essex Cardiothoracic Centre, Essex, UK       
  • OCT 2012 - SEPT 2013: Post CCT Senior TAVI/Structural Interventional FellowKing’s College Hospital, London.
  • AUG 2007 - OCT 2012: Specialist Training (ST) rotation – Cardiology (Intervention) East of England Deanery 

Certifications & Professional Memberships

MEMBERSHIPS:

  • The Fellowship of The American College of Cardiology (FACC)
  • The Fellowship of The Royal College of Physicians (London)- FRCP
  • The Fellowship of European Society of Cardiology (FESC)
  • British Cardiovascular society (BCS)
  • British Cardiovascular Intervention Society (BCIS)
  • European Association of Percutaneous cardiovascular intervention (EAPCI)
  • American Heart Association (AHA)

Medical Council Registration

62799

Special Interests

  • ADVANCED INTERVENTIONAL CARDIOLOGY
  • TAVI
  • COMPLEX CORONARY ANGIOPLASTY
  • PACEMAKER
  • ASD
  • ICD
  • Specialises in Advanced Interventional Cardiology (advanced coronaryand advanced structural) and has immense experience in managing all forms of heart disorders (coronary artery disease including heart attack, valvular heart disease, heart failure including cardiomyopathies and rhythm disorder). He performs all forms of Percutaneous Coronary Intervention (PCI)- coronary angioplasty with stents– including primary PCI for ST elevation MI (acute heart attack- unblocking the closed artery), chronic total occlusion (CTO) angioplasty with latest techniques such as crossboss and stingray balloons,  rotablation (drilling technique) , bifurcation stenting, Left main stem (LMS) stenting (main branch), Bio-absorbable scaffold (BVS) deployment, dedicated bifurcation stenting (Tryton), Drug eluting balloon (DEB), Intravascular ultrasound (IVUS), Optical coherence tomography (OCT), pressure wire studies (FFR- fractional flow reserve), mechanical thrombectomy, proximal and distal protection devices, vein graft stenting both via radial and femoral approach. Presently the default strategy is radial access including complex interventions.